Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Plasmapp Co., Ltd. (405000:KRX), powered by AI.
Plasmapp Co., Ltd. is currently trading at ₩4,350. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Plasmapp Co., Ltd. on Alpha Lenz.
Plasmapp Co., Ltd.'s P/E ratio is -2.9.
“Plasmapp Co., Ltd. trades at a P/E of -2.9 (undervalued) with modest ROE of -128.6%.”
Ask for details →Plasmapp Co., Ltd. is a biotechnology company focused on the development and production of plasma-based sterilization and disinfection devices. Operating in the healthcare and medical equipment sector, Plasmapp primarily aims to enhance the sterilization processes used in hospitals, dental clinics, and laboratories, providing state-of-the-art solutions that improve safety and efficiency. The company's innovative technologies are designed to tackle the challenges of traditional sterilization methods, such as time consumption and heat damage to sensitive medical instruments. Plasmapp's commitment to research and development ensures its products meet the rigorous standards required in the medical field, and its influence extends globally as it seeks to expand its market presence and address increasing demands for reliable sterilization techniques in the healthcare industry. With a focus on technological advancement and customer satisfaction, Plasmapp Co., Ltd. plays a significant role in advancing healthcare innovation and improving patient safety.
“Plasmapp Co., Ltd. trades at a P/E of -2.9 (undervalued) with modest ROE of -128.6%.”
Ask for details →Plasmapp Co., Ltd. (ticker: 405000) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 61 employees. Market cap is $18.9B.
The current price is ₩4,350 with a P/E ratio of -2.87x and P/B of 3.31x.
ROE is -128.57% and operating margin is -89.60%. Annual revenue is $8.5B.